MINSK, 13 January (BelTA) – The commercial effect from the projects to be implemented in the R&D park Belbiograd is supposed to reach $500 million by 2023, BelTA learned from Deputy Chairman of the Presidium of the National Academy of Sciences of Belarus (NASB) Sergei Kilin.
The official said that 26 projects had been fleshed out so far. By 2023 the projects are supposed to earn about half a billion U.S. dollars for the state. “The projects will produce new medications, new pharmaceutical products, and new nanotechnologies,” said Sergei Kilin.
Belbiograd is an infrastructure formation based on existing organizations such as Academpharm, the Bioorganic Chemistry Institute, the New Materials Chemistry Institute, and the Microbiology Institute. The park is expected to bring together institutions focusing on R&D in bio-, nano-, medical, and agrarian technologies. The project was initiated by the Economy Ministry in 2011. In October 2013 as a result of the government conference the National Academy of Sciences of Belarus was tasked with further efforts to establish Belbiograd.
As far as robot technology development is concerned, the National Academy of Sciences of Belarus is ready to work together with young innovators, who have startups of their own. An artificial intelligence center operates as part of the Academy of Sciences. A robot technology lab was established a short while ago.